Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Using credit card points for travel deals can significantly reduce your expenses. Discover how to leverage your points for savings.
19,634 articlesTeva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
AMD and Intel report mixed Q1 2026 results as AI data-center demand surges. AMD-led momentum in data center contrasts...
Intel shares surged in premarket trading after President Trump floated a plan for Intel to build chips for Apple in t...
AI headlines sent IT-services stocks lower, but is the pullback justified? This guide explains what drives the move, ...
Entrepreneurship powered America’s rise, and Steve Case argues we must expand that engine nationwide to guard the cou...
When celebrities chase big stunts, their money decisions often follow. This article turns that idea into clear, actio...
Oracle reports a powerful cloud quarter and record backlog, signaling a potential future milestone. Yet mounting capi...
As AI moves from experiments to real workloads, the need for secure, low-latency data paths grows. This look explores...
As July 22 approaches, investors wonder if AMD stock could spark a move. This guide breaks down catalysts, risks, and...
A USMCA review is on the radar as supply chains evolve and tariffs shift. This article breaks down why extending the ...
A sharp market pullback followed a bold political statement about the Iran deal. This guide breaks down what happened...
Ciena’s shares jumped sharply in the first half of 2026. This article dives into the AI-driven demand for optical net...